Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolonged Vaginal Progesterone to Prevent Preterm Birth in IVF
NCT05787509Phase 4Recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Apr 2023
- Primary completion
- Apr 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Crinone in preterm birth (2 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Incidence of preterm birth at 37 weeks. Started Apr 2023; status: recruiting.
02
Drugs
Crinone
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT05787509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05787509.